Publications
- Adalimumab versus infliximab in pediatric patients with Crohn's disease: A propensity-score analysis and predictors of treatment escalation2022 | Second Faculty of Medicine
- Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease2021 | Second Faculty of Medicine
- Inflammatory bowel diseases in children2021 | Second Faculty of Medicine
- Guidelines for the administration of biological therapy in patients with inflammatory bowel diseases: fourth, updated edition2019 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Opinion of the Working Group on Pediatric Gastroenterology, Hepatology and Nutrition of the Czech Pediatric Society (PSDG ČPS) on the use of dietary measures in the treatment of Crohn's disease in pediatric patients2019 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Vedolizumab vs. Ustekinumab as second-line therapy in Crohn's disease in clinical practice2019 | First Faculty of Medicine
- CDED diet in induction therapy of Crohn's disease2019 | Publication without faculty affiliation
- Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort2017 | First Faculty of Medicine
- Guidelines for the administration of biological therapy in patients with inflammatory bowel diseases: third, updated edition2016 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation2016 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...